Risultati di ricerca
Christopher Boerner is board chair and chief executive officer at Bristol Myers Squibb. Prior to assuming his current role, he served as executive vice president, chief operating officer and chief executive officer designate from April to November 2023.
Dr. Christopher Boerner, age 53, serves as board chair for Bristol Myers Squibb since April 2024 and chief executive officer since November 2023. Prior to assuming that role, he was executive vice president, chief operating officer and chief executive officer designate since April 2023.
- Board Chair And Chief Executive Officer
- Bristol Myers Squibb
31 ott 2023 · Christopher Boerner has served as EVP, Chief Operating Officer and CEO-elect since April 26, 2023. He was appointed EVP, Chief Commercialization Officer on August 28, 2018, where he led the...
31 ott 2023 · PRINCETON, N.J.-- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) announced that its Board of Directors has unanimously elected Christopher Boerner, Ph.D., to serve as Chair of the Board, effective April 1, 2024. He succeeds Giovanni Caforio, M.D., who will step down as Chair of the Board on April 1, 2024 and retire from the ...
31 ott 2023 · Christopher Boerner has served as EVP, Chief Operating Officer and CEO-elect since April 26, 2023. He was appointed EVP, Chief Commercialization Officer on August 28, 2018, where he led the...
25 apr 2024 · C hristopher Boerner, 53, took over as the chief executive officer of Bristol Myers Squibb last November, and immediately made a big move: a series of three acquisitions totaling $24 billion...
3 ott 2022 · We’re proud to announce Chris Boerner, our chief commercialization officer, has been named to the Biotechnology Innovation Organization (BIO) Board of Directors to help build a sustainable...
